WebJul 20, 2024 · Biogen : Reports Q2 2024 Earnings. Second quarter revenue $2,589 million; GAAP diluted EPS $7.24; Non-GAAP diluted EPS $5.25. FDA granted Priority Review for lecanemab in early Alzheimer's disease under the accelerated approval pathway with a decision expected by January 6, 2024; Phase 3 data expected in the Fall of 2024. WebApr 13, 2024 · Biogen Inc. has a 12-month low of $187.16 and a 12-month high of $311.88. Biogen (NASDAQ:BIIB - Get Rating) last issued its quarterly earnings data on Wednesday, February 15th. The biotechnology company reported $4.05 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.48 by $0.57.
Presentations Investor Relations Biogen
WebJul 20, 2024 · Biogen Inc. (BIIB) came out with quarterly earnings of $5.25 per share, beating the Zacks Consensus Estimate of $4.09 per share. This compares to earnings … WebJul 20, 2024 · Biogen Inc. (BIIB) delivered earnings and revenue surprises of 28.36% and 4.69%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? phonk beat downloader
Burning Rock Biotech Limited (BNR) Q2 2024 Earnings Call …
WebJul 22, 2024 · Biogen Inc. (BIIB) CEO Michel Vounatsos on Q2 2024 Results - Earnings Call Transcript. Seeking Alpha • 07/22/20. Biogen Beats Second-Quarter Expectations. The Motley Fool • 07/22/20. Top Value Stocks For July. ... Biogen (BIIB) Beats on Q2 Earnings, Raises EPS View, Stock Up. Zacks Investment Research • 07/22/20. WebApr 6, 2024 · Biogen last issued its quarterly earnings results on February 15th, 2024. The biotechnology ... WebRegeneron Pharmaceuticals Q2 2024 Earnings Conference Call. Listen to Regeneron Pharmaceuticals Q2 2024 Earnings Conference Call webcast. Regeneron Corporate Presentation August 2024 2.3 MB. Jun 14 2024 11:40 AM EDT Jun 14, 2024 11:40 AM EDT. Goldman Sachs 43rd Annual Global Healthcare Conference. how do you use gentle reminder in a sentence